chr16-3966843-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001116.4(ADCY9):c.2994C>T(p.Arg998=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00937 in 1,614,182 control chromosomes in the GnomAD database, including 85 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0063 ( 5 hom., cov: 33)
Exomes 𝑓: 0.0097 ( 80 hom. )
Consequence
ADCY9
NM_001116.4 synonymous
NM_001116.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.50
Genes affected
ADCY9 (HGNC:240): (adenylate cyclase 9) Adenylate cyclase is a membrane bound enzyme that catalyses the formation of cyclic AMP from ATP. It is regulated by a family of G protein-coupled receptors, protein kinases, and calcium. The type 9 adenylyl cyclase is a widely distributed adenylyl cyclase, and it is stimulated by beta-adrenergic receptor activation but is insensitive to forskolin, calcium, and somatostatin. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 16-3966843-G-A is Benign according to our data. Variant chr16-3966843-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 769893.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.5 with no splicing effect.
BS2
High AC in GnomAd4 at 957 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADCY9 | NM_001116.4 | c.2994C>T | p.Arg998= | synonymous_variant | 11/11 | ENST00000294016.8 | |
ADCY9 | XM_005255079.4 | c.3051C>T | p.Arg1017= | synonymous_variant | 11/11 | ||
ADCY9 | XM_011522353.3 | c.2927+7826C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADCY9 | ENST00000294016.8 | c.2994C>T | p.Arg998= | synonymous_variant | 11/11 | 1 | NM_001116.4 | P1 | |
ADCY9 | ENST00000576936.5 | c.567+7826C>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00629 AC: 957AN: 152198Hom.: 5 Cov.: 33
GnomAD3 genomes
AF:
AC:
957
AN:
152198
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00584 AC: 1469AN: 251418Hom.: 7 AF XY: 0.00586 AC XY: 796AN XY: 135904
GnomAD3 exomes
AF:
AC:
1469
AN:
251418
Hom.:
AF XY:
AC XY:
796
AN XY:
135904
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00969 AC: 14161AN: 1461866Hom.: 80 Cov.: 35 AF XY: 0.00941 AC XY: 6842AN XY: 727236
GnomAD4 exome
AF:
AC:
14161
AN:
1461866
Hom.:
Cov.:
35
AF XY:
AC XY:
6842
AN XY:
727236
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00628 AC: 957AN: 152316Hom.: 5 Cov.: 33 AF XY: 0.00584 AC XY: 435AN XY: 74480
GnomAD4 genome
AF:
AC:
957
AN:
152316
Hom.:
Cov.:
33
AF XY:
AC XY:
435
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2023 | ADCY9: BP4, BP7, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at